Ainos, Inc. (AIMD )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol AIMD
- Company Ainos, Inc.
- Price $2.31
- Changes Percentage 34.3
- Change 0.59
- Day Low $1.94
- Day High $2.34
- Year High $4.5
- Year Low $1.61
- Market Cap $11,137,044
- Price Avg 50 EMA (D) $2.01
- Price Avg 200 EMA (D) $2.86
- Exchange NASDAQ
- Volume 29,734,218
- Average Volume 44,493
- Open $2.04
- Previous Close $1.72
- EPS -3.92
- PE -0.59
- Earnings Announcement 2026-03-06 05:00:00
- Shares Outstanding $4,821,440
Company brief: AINOS, INC. (AIMD )
- Healthcare
- Biotechnology
- Mr. Chun-Hsien Tsai
- https://ainos.com
- US
- N/A
- 01-08-2021
- US00902F3038
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.